Cargando…

Cost-Effectiveness of Preemptive Switching to Efavirenz-Based Antiretroviral Therapy for Children With Human Immunodeficiency Virus

BACKGROUND: The NEVEREST-3 (South Africa) and MONOD-ANRS-12206 (Côte d’Ivoire, Burkina Faso) randomized trials found that switching to efavirenz (EFV) in human immunodeficiency virus–infected children >3 years old who were virologically suppressed by ritonavir-boosted lopinavir (LPV/r) was noninf...

Descripción completa

Detalles Bibliográficos
Autores principales:	Desmonde, Sophie, Frank, Simone C, Coovadia, Ashraf, Dahourou, Désiré L, Hou, Taige, Abrams, Elaine J, Amorissani-Folquet, Madeleine, Walensky, Rochelle P, Strehlau, Renate, Penazzato, Martina, Freedberg, Kenneth A, Kuhn, Louise, Leroy, Valeriane, Ciaranello, Andrea L
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2019
Materias:	Major Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6634435/ https://www.ncbi.nlm.nih.gov/pubmed/31334298 http://dx.doi.org/10.1093/ofid/ofz276

Ejemplares similares

The value of confirmatory testing in early infant HIV diagnosis programmes in South Africa: A cost-effectiveness analysis
por: Dunning, Lorna, et al.
Publicado: (2017)

Costs of Care of HIV-Infected Children Initiating Lopinavir/Ritonavir-Based Antiretroviral Therapy before the Age of Two in Cote d’Ivoire
por: Desmonde, Sophie, et al.
Publicado: (2016)

Case report: Severe central nervous system manifestations associated with aberrant efavirenz metabolism in children: the role of CYP2B6 genetic variation
por: Pinillos, Francoise, et al.
Publicado: (2016)

Evaluating Point-of-Care Nucleic Acid Tests in Adult Human Immunodeficiency Virus Diagnostic Strategies: A Côte d’Ivoire Modeling Analysis
por: Neilan, Anne M, et al.
Publicado: (2021)

Missed opportunities of inclusion in a cohort of HIV-infected children to initiate antiretroviral treatment before the age of two in West Africa, 2011 to 2013
por: Dahourou, Désiré L, et al.
Publicado: (2016)

HIV Testing After a First Positive Rapid Diagnostic Test: A Role for Nucleic Acid Testing?
por: Neilan, Anne M, et al.
Publicado: (2018)

Efavirenz-based simplification after successful early lopinavir-boosted-ritonavir-based therapy in HIV-infected children in Burkina Faso and Côte d’Ivoire: the MONOD ANRS 12206 non-inferiority randomised trial
por: Dahourou, Désiré Lucien, et al.
Publicado: (2017)

Early infant HIV-1 diagnosis programs in resource-limited settings: opportunities for improved outcomes and more cost-effective interventions
por: Ciaranello, Andrea L, et al.
Publicado: (2011)

Validation and Calibration of a Computer Simulation Model of Pediatric HIV Infection
por: Ciaranello, Andrea L., et al.
Publicado: (2013)

Effect of cotrimoxazole prophylaxis on the incidence of malaria in HIV-infected children in 2012, in Abidjan, Côte d’Ivoire: a prospective cohort study
por: Mounkaila Harouna, Aïda, et al.
Publicado: (2015)

Setting Performance Standards for a Cost-Effective Human Immunodeficiency Virus Cure Strategy in South Africa
por: Paltiel, A. David, et al.
Publicado: (2017)

Cost-effectiveness of Routine Provider-Initiated Testing and Counseling for Children With Undiagnosed HIV in South Africa
por: Stanic, Tijana, et al.
Publicado: (2021)

Risk of Cardiovascular Events Among Patients Initiating Efavirenz-Containing Versus Efavirenz-Free Antiretroviral Regimens
por: Rosenblatt, Lisa, et al.
Publicado: (2016)

Developing and Validating Metamodels of a Microsimulation Model of Infant HIV Testing and Screening Strategies Used in a Decision Support Tool for Health Policy Makers
por: Soeteman, Djøra I., et al.
Publicado: (2020)

Virological response and resistances over 12 months among HIV-infected children less than two years receiving first-line lopinavir/ritonavir-based antiretroviral therapy in Cote d’Ivoire and Burkina Faso: the MONOD ANRS 12206 cohort
por: Amani-Bosse, Clarisse, et al.
Publicado: (2017)

Optimal breastfeeding durations for HIV‐exposed infants: the impact of maternal ART use, infant mortality and replacement feeding risk
por: Mallampati, Divya, et al.
Publicado: (2018)

Transition from paediatric to adult care of adolescents living with HIV in sub-Saharan Africa: challenges, youth-friendly models, and outcomes
por: Dahourou, Désiré Lucien, et al.
Publicado: (2017)

Pregnancy incidence and associated factors among HIV-infected female adolescents in HIV care in urban Côte d'Ivoire, 2009–2013
por: Arikawa, Shino, et al.
Publicado: (2016)

The Linkage Outcomes of a Large-scale, Rapid Transfer of HIV-infected Patients From Hospital-based to Community-based Clinics in South Africa
por: Cloete, Christie, et al.
Publicado: (2014)

Prenatal Transmission of Syphilis and Human Immunodeficiency Virus in Brazil: Achieving Regional Targets for Elimination
por: Cerda, Rodrigo, et al.
Publicado: (2015)

Immunological, Cognitive, and Psychiatric Outcomes After Initiating Efavirenz- and Dolutegravir-based Antiretroviral Therapy During Acute Human Immunodeficiency Virus Infection
por: Chan, Phillip, et al.
Publicado: (2022)

Projected Benefits of Long-Acting Antiretroviral Therapy in Nonsuppressed People With Human Immunodeficiency Virus Experiencing Adherence Barriers
por: Chen, Wanyi, et al.
Publicado: (2023)

Assessment of a Clinical Pharmacy Activity in a Pediatric Inpatient Department in Cote D’ivoire
por: Abrogoua, Danho Pascal, et al.
Publicado: (2016)

Persistence of Human Immunodeficiency Virus-1 Drug Resistance Mutations in Proviral Deoxyribonucleic Acid After Virologic Failure of Efavirenz-Containing Antiretroviral Regimens
por: De La Cruz, Justin, et al.
Publicado: (2019)

Point-of-Care CD4 Testing to Inform Selection of Antiretroviral Medications in South African Antenatal Clinics: A Cost-Effectiveness Analysis
por: Ciaranello, Andrea L., et al.
Publicado: (2015)

The Survival Benefits of Antiretroviral Therapy in South Africa
por: April, Michael D., et al.
Publicado: (2014)

Severe morbidity and mortality in untreated HIV-infected children in a paediatric care programme in Abidjan, Côte d'Ivoire, 2004-2009
por: Desmonde, Sophie, et al.
Publicado: (2011)

A Randomized Comparison of Anthropomorphic Changes With Preferred and Alternative Efavirenz-Based Antiretroviral Regimens in Diverse Multinational Settings
por: Erlandson, Kristine M., et al.
Publicado: (2015)

Sex differences in responses to antiretroviral treatment in South African HIV-infected children on ritonavir-boosted lopinavir- and nevirapine-based treatment
por: Shiau, Stephanie, et al.
Publicado: (2014)

Age at antiretroviral therapy initiation and cell-associated HIV-1 DNA levels in HIV-1-infected children
por: Kuhn, Louise, et al.
Publicado: (2018)

Durability of Efavirenz Compared With Boosted Protease Inhibitor-Based Regimens in Antiretroviral-Naïve Patients in the Caribbean and Central and South America
por: Caro-Vega, Yanink, et al.
Publicado: (2018)

Cytomegalovirus (CMV) Disease Despite Weekly Preemptive CMV Strategy for Recipients of Solid Organ and Hematopoietic Stem Cell Transplantation
por: Lodding, I P, et al.
Publicado: (2018)

Clinical, Laboratory, and Radiologic Characteristics of Patients With Initial False-Negative Severe Acute Respiratory Syndrome Coronavirus 2 Nucleic Acid Amplification Test Results
por: Dugdale, Caitlin M, et al.
Publicado: (2020)

Impact of Raltegravir or Efavirenz on Cell-Associated Human Immunodeficiency Virus-1 (HIV-1) Deoxyribonucleic Acid and Systemic Inflammation in HIV-1/Tuberculosis Coinfected Adults Initiating Antiretroviral Therapy
por: Delagreverie, Héloïse M, et al.
Publicado: (2020)

Assessment of dietary diversity and nutritional support for children living with HIV in the IeDEA pediatric West African cohort: a non-comparative, feasibility study
por: Jesson, Julie, et al.
Publicado: (2021)

Potential Clinical and Economic Value of Long-Acting Preexposure Prophylaxis for South African Women at High-Risk for HIV Infection
por: Walensky, Rochelle P., et al.
Publicado: (2016)

Clinical Outcomes After Viremia Among People Receiving Dolutegravir vs Efavirenz-Based First-line Antiretroviral Therapy in South Africa
por: Asare, Kwabena, et al.
Publicado: (2023)

Decreased bone turnover in HIV-infected children on antiretroviral therapy
por: Shiau, Stephanie, et al.
Publicado: (2018)

Cost-effectiveness of first-line antiretroviral therapy for HIV-infected African children less than 3 years of age
por: Ciaranello, Andrea L., et al.
Publicado: (2015)

Empiric vs Preemptive Antifungal Strategy in High-Risk Neutropenic Patients on Fluconazole Prophylaxis: A Randomized Trial of the European Organization for Research and Treatment of Cancer
por: Maertens, Johan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_okm6vd8pbjt40v6l3qg5htaogu